Preventing Dementia
- 1 May 2001
- journal article
- review article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 28 (S1), S56-S66
- https://doi.org/10.1017/s0317167100001219
Abstract
Primary prevention will become increasingly important as dementia prevalence increases and effective retardive therapies are developed. To date, only one randomized controlled trial (involving treatment of systolic hypertension) has demonstrated that the incidence of dementia can be reduced. Physicians should remain alert to possible secondary causes of dementia and correct these whenever possible. Primary and secondary prevention of stroke should reduce dementia related to cerebrovascular disease either directly or as a comorbid factor in Alzheimer's disease (AD). Epidemiological studies have revealed a number of risk factors for AD including genetic mutation, susceptibility genes, positive family history, Down's syndrome, age, sex, years of education, head trauma and neurotoxins. In case-control studies non-steroidal anti-inflammatory medication and estrogen replacement therapy appear to decrease the relative risk of developing AD. Further research to develop and test preventative therapies in AD and other dementias should be strongly encouraged.Keywords
This publication has 126 references indexed in Scilit:
- The Canadian Study of Health and AgingStroke, 1997
- Status of Risk Factors for Dementia Associated With StrokeStroke, 1997
- Epidemiological, Clinical, and Neuropathological Study of Apolipoprotein E Genotype in Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 1996
- Genetic factors in Alzheimer's disease: A review of recent advancesAnnals of Neurology, 1996
- CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?Journal of Toxicology and Environmental Health, 1996
- Estrogen control of central neurotransmission: Effect on mood, mental state, and memoryCellular and Molecular Neurobiology, 1996
- 17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in VitroBiochemical and Biophysical Research Communications, 1995
- Smoking and Alzheimer's Disease: A Review of the Epidemiological EvidenceNeuroepidemiology, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978